PinnyPeptide

Cartalax vs Ovagen

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Cartalax

Bioregulators

Khavinson short peptide bioregulator targeting chondrocytes and connective tissue.

Peptide B

Ovagen

Bioregulators

Khavinson short peptide bioregulator targeting hepatocytes and liver function.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Cartalax effects

  • Reported support of chondrocyte function and cartilage matrix synthesis
  • Improvements in joint pain and mobility (Russian observational)
  • Possible slowing of age-related cartilage degradation
  • Recovery support after cartilage injury
  • Modulation of connective-tissue gene expression

Ovagen effects

  • Reported normalization of elevated liver enzymes
  • Improvement in synthetic liver function markers
  • Support of hepatocyte regeneration
  • Anti-inflammatory effects in chronic liver disease
  • Modulation of hepatic gene expression

Cartalax side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation

Ovagen side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation

Cartalax dosing ranges

Joint / cartilage support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Ovagen dosing ranges

Hepatic support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Full Cartalax guide → Full Ovagen guide →

Cartalax vs Ovagen — common questions

What is the difference between Cartalax and Ovagen?

Cartalax: Khavinson short peptide bioregulator targeting chondrocytes and connective tissue. Typical dose 1,000-5,000 mcg. Ovagen: Khavinson short peptide bioregulator targeting hepatocytes and liver function. Typical dose 1,000-5,000 mcg. Both fall under the Bioregulators category.

Can you stack Cartalax and Ovagen?

Stacking Cartalax with Ovagen is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Cartalax or Ovagen?

Cartalax is typically dosed: Once daily (SubQ) or sublingual for Joint / cartilage support. Ovagen is typically dosed: Once daily (SubQ) or sublingual for Hepatic support.

Are Cartalax and Ovagen FDA approved?

Cartalax: Not FDA approved. Ovagen: Not FDA approved.

Related peptide comparisons

bronchogen vs cartalaxcardiogen vs cartalaxcartalax vs cortagencartalax vs crystagencartalax vs pancragenbronchogen vs ovagen

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free